Results 301 to 310 of about 1,254,012 (356)

Erratum: Predicting the survival probability of functional neuroendocrine tumors treated with peptide receptor radionuclide therapy: Serbian experience

Frontiers in Endocrinology
Frontiers Production Office
doaj   +1 more source

Association of CDKN2A/B Homozygous Deletion and Extent of Resection With Survival of Patients With WHO CNS5 Grade 4 Astrocytoma

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives WHO grade 4 astrocytomas are associated with poor prognosis, and their prognostic factors remain controversial. This study aimed to identify the prognostic factors and develop a management algorithm for these patients. Methods This study retrospectively included 151 CNS5 adult grade 4 astrocytomas from two medical centers.
Jiawei Cai, Guanglin Zhu, Qiu He, Chen Luo, Lingyun Zhuo, Xingfu Wang, Yiming Chen, Xiaoyong Chen, Wendong You, Jiaheng Xu, Yuanxiang Lin, Dezhi Kang, Shuai Wu, Zanyi Wu   +13 more
wiley   +1 more source

Progression-Free Survival Under Immune Checkpoint Inhibitors for Metastatic Non-Small-Cell Lung Cancer: A Retrospective Cohort Study. [PDF]

Oncol Ther
Boré P, Geier M, Campion L, Raoul JL, Doucet L, Hiret S, Bigot F, Bocquet F, Mezquita L, Gorria T, Raimbourg J.   +10 more
europepmc   +1 more source

Comparative study on the predictive value of TyG, TyG-BMI, and TG/HDL-C for progression-free survival in patients with locally advanced nasopharyngeal carcinoma. [PDF]

Front Nutr
Xiao Z, Liang Z, Chen W, Huang H, Qu S.
europepmc   +1 more source

Prognostic Value of Pre-Treatment Diffusion Kurtosis Imaging for Progression-Free Survival Prediction in Advanced Nasopharyngeal Carcinoma. [PDF]

Cancer Med
Ren W, Zheng X, Wu S, Wu C, Zheng D.
europepmc   +1 more source

The Effect of Staging Intervals on Progression-Free Survival in Registration Studies of Oncologic Drugs: A Meta-Analysis. [PDF]

Cancers (Basel)
Zuellig JA, Adam R, Udry F, Tibau A, Šeruga B, Ocaña A, Amir E, Templeton AJ.   +7 more
europepmc   +1 more source

Relationship between HuR and patients’ outcome was estimated with pan-cancer disease specific survival (DSS), disease-free interval (DFI), and progression-free interval (PFI) analysis.

Jian Peng (117876), Jichuan Quan (11406050), Xiaoru Wang (345528)   +2 more
openalex   +1 more source

Integrating radiology and histology via co-attention deep learning for predicting progression-free survival in patients with metastatic prostate cancer. [PDF]

Chin Med J (Engl)
Zhao Y, Liu F, Zhu C, Yan C, Fu B, He J, Xie X, Wang R, Li Z.   +8 more
europepmc   +1 more source

Osimertinib prolongs progression‐free lung cancer survival after chemotherapy

CA: A Cancer Journal for Clinicians
openaire   +2 more sources